Sound Shore Management Inc CT increased its stake in shares of Perrigo Company plc (NYSE:PRGO – Free Report) by 11.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,650,998 shares of the company’s stock after acquiring an additional 363,327 shares during the quarter. Perrigo comprises approximately 2.7% of Sound Shore Management Inc CT’s portfolio, making the stock its 21st largest holding. Sound Shore Management Inc CT owned about 2.65% of Perrigo worth $81,308,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors also recently bought and sold shares of the stock. LSV Asset Management increased its position in shares of Perrigo by 62.1% during the third quarter. LSV Asset Management now owns 133,900 shares of the company’s stock worth $2,982,000 after purchasing an additional 51,300 shares in the last quarter. Caprock Group LLC purchased a new position in Perrigo during the 3rd quarter worth approximately $592,000. Bryce Point Capital LLC acquired a new position in Perrigo during the third quarter worth approximately $377,000. Diamond Hill Capital Management Inc. lifted its stake in Perrigo by 8.6% in the third quarter. Diamond Hill Capital Management Inc. now owns 1,797,746 shares of the company’s stock valued at $40,036,000 after buying an additional 142,363 shares during the last quarter. Finally, American Assets Inc. purchased a new stake in Perrigo in the third quarter valued at approximately $601,000. Institutional investors and hedge funds own 95.91% of the company’s stock.
Perrigo Price Performance
Shares of PRGO opened at $14.59 on Thursday. The company has a current ratio of 2.51, a quick ratio of 1.44 and a debt-to-equity ratio of 0.81. The stock’s 50 day moving average is $14.12 and its two-hundred day moving average is $18.37. Perrigo Company plc has a twelve month low of $12.17 and a twelve month high of $30.93. The firm has a market capitalization of $2.01 billion, a PE ratio of -38.38, a P/E/G ratio of 1.29 and a beta of 0.39.
Wall Street Analyst Weigh In
View Our Latest Stock Report on Perrigo
About Perrigo
Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.
Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.
Recommended Stories
- Five stocks we like better than Perrigo
- Is THIS the Next Big Money Rush?
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- The Crash Has Already Started (Most Just Don’t See It Yet)
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO – Free Report).
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.
